TICAROS

TiCARos

OVERVIEW OF THE COMPANY

Next Generation

Immunotherapy

TiCARos Co.Ltd is a biotech company which develops the next generation immunotherapeutics for cancers.

Recently, alongside with antibody techniques, the immuno-oncology therapies are evolving into novel cellular therapeutics which harbor immune cell therapies and gene therapies together. Especially, the outstanding clinical efficacy of CAR-T cell therapies and the potential for successful TCR-T therapies are leading a new era of cancer therapeutics

TiCARos develops matchless CAR-T and cell therapeutics for cancer treatment, by leveraging accumulated experiences and technologies of the immunologists at Seoul National University, College of Medicine. We hope that these efforts will lead to a novel breakthrough in treatment of not only intractable hematologic malignancies but also of advanced solid tumors.

MISSION

" We create novel therapeutics based on Science "

“We will contribute to human welfare by providing a breakthrough in medicine”

Passion

Intergrity

Creativity

HISTORY

TiCARos:
From Research to Therapeutics

- ·
  R&D, Business Partnership Cartherics, Ltd
- ·
  
  Grants
  
  KDDF New Drug R&D Funding($1M)
  
  Ministry of SMEs($0.5M)
  Ministry of Trade, Industry and Energy
  
  Ministry of Health & Welfare:Medical Global Collaboration($1.5M/yr)
- ·
  Open Innovation J&J – JLABS Korea
- ·
  R&D, Business Partnership Undisclosed
2024
- ·
  IND Approved (ROK) TC011(Phase I & II)
- ·
  
  Grants
  
  KDDF Clinical Trial Funding($1.5M)
  
  Ministry of SMEs($0.1M)
  
  Ministry of Science and ICT(POSTECH)
- ·
  Presentation ’23 BIO-International
2022~2023
- ·
  HQ, R&D Center Relocation: Seongsu, Seoul
- ·
  BAB Prof. Peter Kash, Ed.D. MBA
- ·
  CLIP CAR-T Patent Reg.(KR), PCT App.
- ·
  
  Grants
  
  Ministry of SMEs($0.1M)
  
  KDDF Drug Development($1M)
  
  KDDF R&D Funding($1M)
- ·
  Funding Series C $22M
2021

2020
- ·
  CLIP CAR-T Patent Application
- ·
  
  Grant
  
  Ministry of Health & Welfare($2M)
  
  Ministry of Trade, Industry and Energy
- ·
  SAB Prof. Yoon (President, Hematologic Oncology Society)
- ·
  R&D Partnership SNU College of Medicine
2019
- ·
  CLIP CAR-T R&D
- ·
  Funding Series A&B: $8M
- ·
  
  Grant
  
  Ministry of SMEs ($0.1M)
2018
- ·
  TICAROS Est, Jun 2018
- ·
  R&D Partnership National Cancer Center, Korea
2008~2017
- ·
  CONVERTER CAR-T
  - - R&D/ Patent App. (KR)
  - - Publication (Blood)
  - - Patent Regi. (KR, US, JP)

Key members

Jae Won Lee

CEO / Founder
- Director, Dream Tech Investment
- Treasury, HSBC, BNP Bank
- B.A., M.A. in Business Administration, Sungkyunkwan University
Kyung Ho Choi

CTO / Founder
- Scientific Committee Chair, Korean Association of Immune Cell Engineering and Therapy (KAICET)
- Associate Professor, Seoul National University College of Medicine (Immunobiochemistry)
- Principal Investigator, National Cancer Center, Korea
- PostDoc, NIH, USA (Immunology)
- M.D., Ph. D., Seoul National University College of Medicine (Biochemistry)
Eun Young Choi

CSO / Founder
- Professor, Seoul National University College of Medicine (Immunology)
- PostDoc, Jackson Laboratory, USA (Immunnogenetics)
- Ph. D., Seoul National University College of Medicine (Immunology)
- B.S., M.S., Seoul National University (Biology)
Hyung Bae Park

Director of Research Center
- Visiting Researcher, Cancer Research Institute, Seoul National University
- Assistant Professor, Brain Korea(BK)21 Seoul National University
- Hematologic Malignancy Branch, National Cancer Center
- Ph. D., College of Medicine, Seoul National University (Immunology)
Sun Young Park

Director of Development Center
- Principal Scientist, Samsung Bioepis
- Manager, Healthcare division, SK Telecom
- Ph. D., College of Medicine, Seoul National University (Biochemistry)
Young Soon Na

Leader of Lead Development Team
- Principal Scientist, Asan Institute for Life Sciences
- Research Professor, School of Biotechnology, Korea University
- Ph.D., Seoul National University (Genetic Engineering)
Sung Hoon Jung

Leader of Business Management Headquarters
- Managing Director, Woojin Interlogis
- Olympus Korea Business Management
- Samsung SDS Business Management
- B.A., in Economics, Korea University